Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Myositis autoantibodies and clinical phenotypes.

Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A.

Auto Immun Highlights. 2014 Aug 23;5(3):69-75. doi: 10.1007/s13317-014-0060-4. eCollection 2014 Dec. Review.

2.

Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference.

Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.

Autoimmun Rev. 2015 Apr 14. pii: S1568-9972(15)00086-5. doi: 10.1016/j.autrev.2015.04.004. [Epub ahead of print] Review.

PMID:
25888464
3.

Vaccination in children with allergy to non active vaccine components.

Franceschini F, Bottau P, Caimmi S, Crisafulli G, Lucia L, Peroni D, Saretta F, Vernich M, Povesi Dascola C, Caffarelli C.

Clin Transl Med. 2015 Feb 14;4:3. doi: 10.1186/s40169-014-0043-0. eCollection 2015.

4.

Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients.

Dall'Ara F, Andreoli L, Piva N, Piantoni S, Franceschini F, Tincani A.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):153-8. Epub 2015 Jan 29.

PMID:
25664429
5.

Short Hospitalization System: a new way of interpreting day surgery care.

Rago R, Franceschini F, Tomassini CR.

Minerva Anestesiol. 2014 Dec 23. [Epub ahead of print]

PMID:
25532492
6.

Switching from intravenous to subcutaneous formulation of abatacept: a single-center Italian experience on efficacy and safety.

Reggia R, Franceschini F, Tincani A, Cavazzana I.

J Rheumatol. 2015 Feb;42(2):193-5. doi: 10.3899/jrheum.141042. Epub 2014 Dec 15.

PMID:
25512476
7.

Belimumab for the treatment of refractory systemic lupus erythematosus: real-life experience in the first year of use in 18 Italian patients.

Andreoli L, Reggia R, Pea L, Frassi M, Zanola A, Cartella S, Franceschini F, Tincani A.

Isr Med Assoc J. 2014 Oct;16(10):651-3. No abstract available.

8.

Belimumab for the treatment of refractory systemic lupus erythematosus: real-life experience in the first year of use in 18 Italian patients.

Andreoli L, Reggia R, Pea L, Frassi M, Zanola A, Cartella S, Franceschini F, Tincani A.

Isr Med Assoc J. 2014 Oct;16(10):651-3. No abstract available.

9.

Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.

Bruschi M, Galetti M, Sinico RA, Moroni G, Bonanni A, Radice A, Tincani A, Pratesi F, Migliorini P, Murtas C, Franceschini F, Trezzi B, Brunini F, Gatti R, Tardanico R, Barbano G, Piaggio G, Messa P, Ravani P, Scolari F, Candiano G, Martini A, Allegri L, Ghiggeri GM.

J Am Soc Nephrol. 2014 Nov 14. pii: ASN.2014050493. [Epub ahead of print]

PMID:
25398787
10.

Effects of immune system on long-term results of cardiac resynchronization therapy.

Mascioli G, Lombardi C, Franceschini F, Metra M, Lucca E, Michelotti F, Canevese F, Bakhtadze N, Belvito C, Sciatti E, Vizzardi E, Bontempi L, Curnis A.

Minerva Cardioangiol. 2014 Oct 13. [Epub ahead of print]

PMID:
25310692
11.

Evaluation of ascending aorta wall in rheumatoid arthritis by tissue and strain Doppler imaging during anti-tumor necrosis factor-α therapy.

Vizzardi E, Cavazzana I, Sciatti E, Bonadei I, D'Aloia A, Tincani A, Franceschini F, Metra M.

Clin Cardiol. 2014 Dec;37(12):738-43. doi: 10.1002/clc.22332. Epub 2014 Sep 18.

PMID:
25236839
12.

Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality.

Dall'Ara F, Reggia R, Taraborelli M, Andreoli L, Taglietti M, Frassi M, Franceschini F, Tincani A.

Lupus. 2014 Oct;23(12):1255-8. doi: 10.1177/0961203314534308.

PMID:
25228719
13.

Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis.

Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):732-4. Epub 2014 Sep 8.

PMID:
25198168
14.

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.

Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, Chan JY, Chan EK, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):891-7. Epub 2014 Aug 15.

PMID:
25151986
15.

Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.

Taraborelli M, Cavazzana I, Fredi M, Airò P, Nascimbeni G, Tincani A, Franceschini F.

Clin Rheumatol. 2015 Apr;34(4):791-4. doi: 10.1007/s10067-014-2694-z. Epub 2014 Jun 11.

PMID:
25028250
16.

Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide.

Taraborelli M, Monari P, Cavazzana I, Gualdi G, Calzavara-Pinton P, Franceschini F.

Joint Bone Spine. 2015 Mar;82(2):130-1. doi: 10.1016/j.jbspin.2014.05.005. Epub 2014 Jun 27. No abstract available.

PMID:
24986684
17.

Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.

Bruschi M, Sinico RA, Moroni G, Pratesi F, Migliorini P, Galetti M, Murtas C, Tincani A, Madaio M, Radice A, Franceschini F, Trezzi B, Bianchi L, Giallongo A, Gatti R, Tardanico R, Scaloni A, D'Ambrosio C, Carnevali ML, Messa P, Ravani P, Barbano G, Bianco B, Bonanni A, Scolari F, Martini A, Candiano G, Allegri L, Ghiggeri GM.

J Am Soc Nephrol. 2014 Nov;25(11):2483-98. doi: 10.1681/ASN.2013090987. Epub 2014 May 1.

PMID:
24790181
18.

In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings.

Venturini M, Arisi M, Zanca A, Cavazzana I, Gonzàlez S, Franceschini F, Calzavara-Pinton P.

Eur J Dermatol. 2014 May-Jun;24(3):349-55. doi: 10.1684/ejd.2014.2321.

PMID:
24721824
19.

Rare autoantibodies to cellular antigens in systemic lupus erythematosus.

Fredi M, Cavazzana I, Quinzanini M, Taraborelli M, Cartella S, Tincani A, Franceschini F.

Lupus. 2014 Feb 20. [Epub ahead of print]

PMID:
24557777
20.

A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.

Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):118-21. Epub 2013 Jul 23.

PMID:
23910615
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk